Table 1 Patients characteristics.
From: Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
Variable | patients no. (%) |
|---|---|
Gender | |
Female | 111 (54.7) |
Male | 134 (45.3) |
Age | |
< 45 y | 200 (81.6) |
≥ 45 y | 45 (18.4) |
Extranodal Involvment (ENI) | |
No | 168 (68.6) |
Yes | 77 (31.4) |
Stage | |
I | 13 (5.3) |
II | 91 (37.1) |
III | 64 (26.1) |
IV | 77 (31.5) |
Bulky mass | |
No | 214 (87.3) |
Yes | 31 (12.7) |
No. of ABVD cycles | |
4 cycles | 28 (11.5) |
6 cycles | 157 (64) |
8 cycles | 60 (24.5) |
